Go to deals
Healthcare

Haydale Graphene Industries has completed a fundraising

Haydale Graphene Industries PLC has raised funds to continue to develop the ongoing commercialization of its proprietary HDPlas® plasma functionalization process.

Haydale is a leading global technology solutions company that specializes in the design, development and commercialization of advanced materials using graphene and other nanomaterials.

Oaklins Cavendish, based in the UK, acted as nominated advisor and broker in connection with Haydale Graphene Industries’ recent fundraising.

Talk to the deal team

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
Gewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.
Other Industries

Gewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.

Gewiss S.p.A. has successfully finalized a mandatory public tender offer for Beghelli S.p.A.

Learn more
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
Private Equity | Construction & Engineering Services | Energy | TMT

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.

Learn more